Citation: Js. Schneider et al., PARKINSONS-DISEASE - IMPROVED FUNCTION WITH GM1 GANGLIOSIDE TREATMENTIN A RANDOMIZED PLACEBO-CONTROLLED STUDY, Neurology, 50(6), 1998, pp. 1630-1636
Citation: Js. Schneider et al., EFFECTS OF CHRONIC GM1 GANGLIOSIDE TREATMENT ON THE PROGRESSION OF PARKINSONS-DISEASE - RESULTS OF A 2-YEAR OPEN STUDY, Neurology, 50(4), 1998, pp. 40006-40006
Citation: Js. Schneider et al., IMPROVEMENT OF PARKINSONS-DISEASE PATIENTS AFTER GM1 GANGLIOSIDE TREATMENT - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY, Neurology, 48(3), 1997, pp. 2003-2003
Authors:
BERNER ES
WEBSTER GD
SHUGERMAN AA
JACKSON JR
ALGINA J
BAKER AL
BALL EV
COBBS CG
DENNIS VW
FRENKEL EP
HUDSON LD
MANCALL EL
RACKLEY CE
TAUNTON D
Citation: Es. Berner et al., PERFORMANCE OF 4 COMPUTER-BASED DIAGNOSTIC SYSTEMS, The New England journal of medicine, 330(25), 1994, pp. 1792-1796
Authors:
KATSETOS CD
FRANKFURTER A
CHRISTAKOS S
MANCALL EL
VLACHOS IN
URICH H
Citation: Cd. Katsetos et al., DIFFERENTIAL LOCALIZATION OF CLASS-III BETA-TUBULIN ISOTYPE AND CALBINDIN-D(28K) DEFINES DISTINCT NEURONAL TYPES IN THE DEVELOPING HUMAN CEREBELLAR CORTEX, Journal of neuropathology and experimental neurology, 52(6), 1993, pp. 655-666